Publicaciones en colaboración con investigadores/as de Universitat Autònoma de Barcelona (2)

2022

  1. The impact of COVID-19 on oncology professionals—one year on: lessons learned from the ESMO Resilience Task Force survey series

    ESMO Open, Vol. 7, Núm. 1

2021

  1. Osimertinib in advanced EGFR-T790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain: OSIREX-Spanish Lung Cancer Group

    BMC Cancer, Vol. 21, Núm. 1